REVANCE THERAPEUTICS INC (RVNC)
US7613301099 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 77.8M 408.50% | 132.6M 70.44% | 234.04M 76.50% | 260.43M 11.28% | 331.29M 27.21% | 423.67M 27.88% | 537.03M 26.76% | 667.54M 24.30% | 757.26M 13.44% | 850.97M 12.37% | |
| EBITDA YoY % growth | -254.85M 3.08% | -238.47M 6.43% | -209.35M 12.21% | -58.14M 72.23% | -2.04M 96.49% | 49.98M 2,550.00% | 110.1M 120.29% | 181.52M 64.87% | 274.04M 50.97% | 359.22M 31.08% | |
| EBIT YoY % growth | -274.7M -0.55% | -272.2M 0.91% | -220.725M 18.91% | -136.84M 38.00% | -69.031M 49.55% | -18.507M 73.19% | 59.257M 420.19% | 132.79M 124.09% | 190.79M 43.68% | 250.7M 31.40% | |
| Operating Margin | -353.08% | -205.28% | -94.31% | -52.54% | -20.84% | -4.37% | 11.03% | 19.89% | 25.19% | 29.46% | |
| EPS YoY % growth | -4.18 13.53% | -3.94 5.74% | -3.79 3.81% | -1.63 57.03% | -1.11 31.58% | -0.56 49.66% | 0.39 169.09% | 1.06 173.68% | 1.39 31.25% | 1.82 30.77% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 52.66% | -0.31 47.24% | -0.20 43.33% | -0.09 75.19% | -0.07 75.67% |
| Revenue Q2Q % growth | 72.727M 4.19% | 73.44M 41.40% | 84.558M 29.32% | 86.496M 44.45% | 92.412M 27.07% |
| EBITDA Q2Q % growth | 18.36M 143.99% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.01M 51.02% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.37 77.30% | -0.39 | 0.02 | 4.62% |
| Q2 2024 Q2Q % growth | -0.36 55.00% | -0.54 | 0.18 | 33.41% |
| Q1 2024 Q2Q % growth | -0.58 21.62% | -0.77 | 0.19 | 24.18% |
| Q4 2023 Q2Q % growth | -0.62 34.74% | -0.74 | 0.12 | 16.06% |
| Q3 2023 Q2Q % growth | -1.63 -39.32% | -0.87 | -0.76 | -87.34% |
| Q2 2023 Q2Q % growth | -0.80 9.09% | -0.79 | -0.01 | -0.84% |
| Q1 2023 Q2Q % growth | -0.74 21.28% | -0.71 | -0.03 | -3.83% |
| Q4 2022 Q2Q % growth | -0.95 -2.15% | -0.97 | 0.02 | 1.86% |
| Q3 2022 Q2Q % growth | -1.17 -6.36% | -0.91 | -0.26 | -28.28% |
| Q2 2022 Q2Q % growth | -0.88 17.76% | -0.88 | 0.00 | -0.32% |
| Q1 2022 Q2Q % growth | -0.94 12.96% | -0.85 | -0.09 | -10.37% |
| Q4 2021 Q2Q % growth | -0.93 25.00% | -1.02 | 0.09 | 8.42% |
| Q3 2021 Q2Q % growth | -1.10 17.91% | -1.18 | 0.08 | 6.39% |
| Q2 2021 Q2Q % growth | -1.07 3.08% | -1.07 | 0.00 | 0.43% |
| Q1 2021 Q2Q % growth | -1.08 6.09% | -1.11 | 0.03 | 2.56% |
| Q4 2020 Q2Q % growth | -1.24 -25.25% | -1.26 | 0.02 | 1.73% |
| Q3 2020 Q2Q % growth | -1.34 -39.58% | -1.05 | -0.29 | -27.34% |
| Q2 2020 Q2Q % growth | -1.10 -28.37% | -1.03 | -0.07 | -6.68% |
| Q1 2020 Q2Q % growth | -1.15 -35.29% | -0.92 | -0.23 | -24.88% |
| Q4 2019 Q2Q % growth | -0.99 11.61% | -0.99 | 0.00 | -0.06% |
| Q3 2019 Q2Q % growth | -0.96 -5.49% | -1.00 | 0.04 | 4.30% |
| Q2 2019 Q2Q % growth | -0.86 8.51% | -0.93 | 0.07 | 7.60% |
| Q1 2019 Q2Q % growth | -0.85 12.37% | -0.89 | 0.04 | 4.46% |
| Q4 2018 Q2Q % growth | -1.12 | -0.96 | -0.16 | -16.54% |
| Q3 2018 Q2Q % growth | -0.91 | -0.99 | 0.08 | 7.87% |
| Q2 2018 Q2Q % growth | -0.94 | -0.96 | 0.02 | 2.31% |
| Q1 2018 Q2Q % growth | -0.97 | -0.73 | -0.24 | -33.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 59.879M 5.47% | 70.222M | -10.343M | -14.73% |
| Q2 2024 Q2Q % growth | 65.389M 12.48% | 67.382M | -1.993M | -2.96% |
| Q1 2024 Q2Q % growth | 51.936M 5.28% | 57.766M | -5.83M | -10.09% |
| Q4 2023 Q2Q % growth | 69.799M 39.82% | 63.359M | 6.44M | 10.16% |
| Q3 2023 Q2Q % growth | 56.776M 95.64% | 60.767M | -3.991M | -6.57% |
| Q2 2023 Q2Q % growth | 58.134M 104.91% | 60.219M | -2.085M | -3.46% |
| Q1 2023 Q2Q % growth | 49.331M 95.29% | 47.023M | 2.308M | 4.91% |
| Q4 2022 Q2Q % growth | 49.92M 92.37% | 47.477M | 2.443M | 5.15% |
| Q3 2022 Q2Q % growth | 29.02M 46.94% | 28.502M | 518K | 1.82% |
| Q2 2022 Q2Q % growth | 28.37M 50.90% | 29.021M | -651K | -2.24% |
| Q1 2022 Q2Q % growth | 25.26M 89.92% | 24.495M | 765K | 3.12% |
| Q4 2021 Q2Q % growth | 25.95M 133.15% | 24.755M | 1.195M | 4.83% |
| Q3 2021 Q2Q % growth | 19.75M 414.32% | 20.699M | -949K | -4.58% |
| Q2 2021 Q2Q % growth | 18.8M 6,166.67% | 15.747M | 3.053M | 19.39% |
| Q1 2021 Q2Q % growth | 13.3M 22,066.67% | 11.199M | 2.101M | 18.76% |
| Q4 2020 Q2Q % growth | 11.13M 12,266.67% | 8.96M | 2.17M | 24.22% |
| Q3 2020 Q2Q % growth | 3.84M 7,580.00% | 1.818M | 2.022M | 111.22% |
| Q2 2020 Q2Q % growth | 300K | 414.63K | -114.63K | -27.65% |
| Q1 2020 Q2Q % growth | 60K -78.57% | 172.89K | -112.89K | -65.30% |
| Q4 2019 Q2Q % growth | 90K -81.63% | 2.341M | -2.251M | -96.16% |
| Q3 2019 Q2Q % growth | 50K -97.88% | 438.6K | -388.6K | -88.60% |
| Q2 2019 Q2Q % growth | -100.00% | 727.056K | -727.056K | -100.00% |
| Q1 2019 Q2Q % growth | 280K 47.37% | 1.167M | -887K | -76.01% |
| Q4 2018 Q2Q % growth | 490K | 1.329M | -839K | -63.13% |
| Q3 2018 Q2Q % growth | 2.36M | 378.42K | 1.982M | 523.65% |
| Q2 2018 Q2Q % growth | 690K | 524.28K | 165.72K | 31.61% |
| Q1 2018 Q2Q % growth | 190K | 5.167M | -4.977M | -96.32% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 19.51% | -13.24% | -13.24% |
| Revenue | 0% | -16.39% | -7.54% | -7.33% |